SmartTRAK will be at the International Neuromodulation Society 13th World Congress “Neuromodulation: Technology Changing Lives” in Edinburgh, Scotland May 27- June 1. Meet with Anne Staylor, Senior SmartTRAK Analyst and Managing Editor!

SmartTRAK Customer Testimonial

SmartTRAK user Eric Vasquez, Product Manager, Advanced Wound Care Marketing, tells why he uses SmartTRAK to stay on top of business intelligence and product and company trends in wound care. 

SmartTRAK Customer Testimonial - Eric Vasquez, Product Manager. 

SmartTRAK  Announces a Mid-Year Data Promotion!

SmartTRAK Attends AANA!

Just a few pictures from AANA-Arthroscopy Association of North America, Denver, Colorado May 18-20.

SmartTRAK Customer Testimonial

SmartTRAK user, Scott Brown, Director Strategic New Market Development, Integra LifeSciences tells why he uses SmartTRAK to manage his business every single day.

Scott Brown Video Testimonial

SmartTRAK just returned from the May 3-5, 2017 EWMA European Wound Management Association Meeting held in Amsterdam.  Great conference! Our very own Susan Paquette,  Vice President and General Manager, Wound for SmartTRAK spoke at the Wound Innovation Symposium on the "State of the Wound Care Market."  We will have an excerpt of the speech up on the blog soon, with the full post of the speech including slides, posted on SmartTRAK.net for our subscribers.

In the meantime, Susan and team have shared a few photos from the conference!

SmartTRAK's Tim Jeavons, Susan Paquette and Lennart Stadler (left to right) attending the 27th conference of European Wound Management Association.  SmartTRAK has local experts in the EU to keep on top of events and news from Europe.  

It’s been less than a year since Nuvectra Medical spun-off from Greatbatch Inc. (now Integer), and in that time Nuvectra has built a sales organization and laid the organizational foundation to become a, multi-indication neurostimulation company.

FDA allowing use of historical controls may overcome a significant barrier and expedite pt enrollment in cartilage repair IDE trials notes Jack Farr, MD, at 2016 ICRS.

Injectable treatments will never turn a bad joint into a good one but may relieve pain for an undetermined period of time, concludes Elizaveta Kon, MD, in a conversation with BioMedGPS at the 2016 ICRS. Dr. Kon has performed extensive research comparing injectable technologies (e.g., PRP, HA, BMAC) and believes their primary role is in treating pain in pts who wish to avoid surgery.